WCN24-432 FINERENONE IN CHINESE PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: A FIDELITY ANALYSIS
Saved in:
| Main Authors: | Ping Li, Yu An, Hongguang Zheng, Weiping Lu, Zhaohui Mo, Xu Xudong, Lu Yibing, Chaoqing Wu, Jingyuan Xie, Nanwei Tong, Fang Liu, Qinkai Chen, Meike Brinker, Dalong Zhu, Zhihong Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924005382 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
WCN25-662 EFFICACY AND SAFETY OF FINERENONE IN PATIENTS WITH NEPHRECTOMY: A FIDELITY SUBANALYSIS
by: Jair Munoz Mendoza, et al.
Published: (2025-02-01) -
WCN25-288 EFFECT OF FINERENONE TREATMENT DISCONTINUATION ON KIDNEY AND CV OUTCOMES IN PATIENTS WITH CKD AND T2D: A FIDELITY SUBANALYSIS
by: Stefan Anker, et al.
Published: (2025-02-01) -
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials
by: George L Bakris, et al.
Published: (2024-03-01) -
Eligibility for finerenone in real-world patients with diabetes and chronic kidney disease: Insights from the FIDELITY pooled analysis
by: Alberto Esteban-Fernández, et al.
Published: (2025-06-01) -
Eligibility for finerenone in real-world patients with diabetes and chronic kidney disease: Insights from the FIDELITY pooled analysis
by: Alberto Esteban-Fernández, et al.
Published: (2025-06-01)